Research & Clinical Trials

The Thrombosis and Hemostasis Program is dedicated to bringing the  highest quality of care to our patients.  As part of that mission, we have active clinical and laboratory research programs at Fletcher Allen Health Care and the University of Vermont.  In addition, we collaborate with scientists and physicians from around the world to move science forward, make new discoveries and find new treatments for patients with clotting and bleeding problems.

Clinical trials are open to patients who wish to participate and meet set entry criteria.  At the link, clinical trials you can find information on studies that are currently open for participation.  If you would like more information on participating in any of these trials, please contact us via our information email THP@vtmednet.org.
 
We have many ongoing research studies designed to improve our understanding of clotting and bleeding.  At our link, Research Studies you will find information on active research studies in our Laboratories.  Some of these studies have participants from around the country and around the world but are not currently open for enrollment in Vermont. 

CURRENTLY OPEN TRIALS

A Randomized Trial to Determine the Impact of Lymphedema Therapy on Qualify of Life and Disease Severity in Patients with Post-Thrombotic Syndrome.
Principal Investigator: Chris E. Holmes, MD, PhD.
Status: Open
Contact:  Karen Gilder, RN:  802-847-4925

A Prospective, Observational Study of Retrievable Inferior Vena Cava Filters
Principal Investigator:  Christopher Morris, M.D.
Status: Open, recruitment by invitation only
Contact:  Patricia Lewis APRN:  802-847-4925                                  

Universal Data and Serum Collection for Persons with Bleeding Disorders
Principal Investigator:  Alan Homans, MD
Status: open for accrual


http://www.cdc.gov/ncbddd/hbd/care_model.htm